Tissue Regenix Group Regulatory News (TRX)

21 Dec 2006 15:17

Oxeco PLC21 December 2006 21 December 2006 Oxeco Plc (the "Company") For the purposes of the transitional provision of the Financial ServicesAuthority Disclosure and Transparency Rules, the total number of 0.1p ordinaryshares of the Company in issue at the date of this notice is 400,000,000, witheach share holding one voting right. The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in the Company, under the Disclosureand Transparency Rules. 21 December 2006 Oxeco Plc Michael Anthony BrethertonExecutive Director This information is provided by RNS The company news service from the London Stock Exchange